WO2003086637A1 - Immunoassay probe - Google Patents

Immunoassay probe Download PDF

Info

Publication number
WO2003086637A1
WO2003086637A1 PCT/US2003/011157 US0311157W WO03086637A1 WO 2003086637 A1 WO2003086637 A1 WO 2003086637A1 US 0311157 W US0311157 W US 0311157W WO 03086637 A1 WO03086637 A1 WO 03086637A1
Authority
WO
WIPO (PCT)
Prior art keywords
probe
magnet
magnetizable
particles
magnetic field
Prior art date
Application number
PCT/US2003/011157
Other languages
French (fr)
Inventor
Eugene K. Achter
Hartmut Richard Schroeder
Stephen S. Trotta
Original Assignee
Instrumentation Laboratory Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instrumentation Laboratory Company filed Critical Instrumentation Laboratory Company
Priority to EP03746724A priority Critical patent/EP1494814A1/en
Priority to AU2003226075A priority patent/AU2003226075B2/en
Priority to CA002481545A priority patent/CA2481545A1/en
Priority to JP2003583638A priority patent/JP2005522679A/en
Publication of WO2003086637A1 publication Critical patent/WO2003086637A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C1/00Magnetic separation
    • B03C1/02Magnetic separation acting directly on the substance being separated
    • B03C1/28Magnetic plugs and dipsticks
    • B03C1/288Magnetic plugs and dipsticks disposed at the outer circumference of a recipient
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C2201/00Details of magnetic or electrostatic separation
    • B03C2201/26Details of magnetic or electrostatic separation for use in medical applications
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/0098Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/11Automated chemical analysis
    • Y10T436/113332Automated chemical analysis with conveyance of sample along a test line in a container or rack

Definitions

  • This invention relates to clinical diagnostic assays, in particular, immunoassays utilizing magnetizable particles and methods thereof.
  • Immunoassays such as chemiluminescent immunoassays, generally require two antibody preparations, a first antibody used to capture and immobilize a target antigen molecule, and a second antibody used to attach a detection label to the antigen.
  • Immobilization of the antigen to be detected in an immunoassay may be accomplished using magnetizable beads, and detection may be accomplished by using a suitable visualant such as isoluminol chemiluminescence.
  • the assay involves the following major steps. For example, a sample containing the antigen is mixed with a first antibody to the antigen which is coupled to magnetizable latex beads, and the mixture is allowed to react. A second antibody, typically to a different epitope on the antigen, coupled to isoluminol, is added to the sample in step 1 and the mixture is allowed to react. A magnetic field is applied to retain the magnetizable beads (with antigen bound, labeled antibody) against the inside wall of the container.
  • a wash fluid is introduced to remove the unbound labeled antibody. Washing the magnetizable beads typically occurs by immobilizing the beads in the magnetic field, introducing a wash fluid, removing the magnetic field, and repeatedly expelling beads into and aspirating the beads from a container to recover all of the beads and to homogeneously mix and resuspend the beads in the wash fluid.
  • the magnetizable beads with antigen bound, labeled antibody are resuspended in a suitable optical cuvette.
  • An activating reagent such as hydrogen peroxide which activates isoluminol is added with the beads in the cuvette and light is emitted in a chemiluminescent reaction. The light emitted from the chemiluminescent reaction is detected using a suitable photodetector. For some applications, additional steps of reagent addition and/or washing may be necessary.
  • the invention described herein features an analytical instrument including a probe with a reservoir, a dilutor assembly for introducing fluid containing magnetizable particles into the probe reservoir, and a plurality of magnetic devices for applying a magnetic field gradient to the particles in the probe reservoir.
  • the analytical instrument has a magnetic washing station and a sampling station.
  • the probe containing magnetic particles in the probe reservoir is moved into the magnetic washing station, that includes the magnets.
  • the magnets include, for example, at least a first magnet and a second magnet, the second magnet having a magnetic field of different magnitude than the first magnet.
  • Other magnetic devices are contemplated by the invention, such as one or more solenoid coils, and are not limited to the magnetic devices decried herein.
  • the invention includes a device for manipulating a magnetizable particle in a fluid medium.
  • the device may be used in an analytical instrument for determining the presence or measuring the quantity of an analyte in body fluids.
  • the device includes a probe for holding and transporting the magnetizable particles and the probe is transportable to a plurality of positions.
  • the device further includes a first magnet for generating a first magnetic field, and a second magnet for generating a second magnetic field.
  • the probe is moveable in a plurality of probe positions between the first and second magnets. At least one of the probe positions immobilizes the magnetic particles in the fluid medium and at least another position resuspends the particles in a fluid medium.
  • the magnetizable beads are immobilized against an inner wall of the probe.
  • the inner wall of the probe may be curved or flat.
  • the magnitude of the first magnetic field is different than the magnitude of the second magnetic field.
  • the first magnet is in the range of about 1 to 5 times the strength of the second magnet.
  • the first magnet is in the range of about 1 to 2 times the strength of the second magnet.
  • the first magnet is separated from the second magnet by a gap in the range of about 1/16 inch to 40 inches, preferably, 1.5 to 2.5 inches, more preferably 1.95 inches.
  • the device has a transport stage for moving the probe between the plurality of probe positions.
  • the transport stage may also move the probe between a sample station and a magnetic washing station.
  • the probe has a thermal control element, and/or a liquid sensing element.
  • the device has a dilutor assembly for introducing a fluid from a fluid reservoir into the probe reservoir through the top end of the probe.
  • the top end of the probe is opposite to an end of the probe used for receiving a sample.
  • the dilutor assembly introduces fluid to the sample end of the probe.
  • the invention is a method for washing a magnetizable particle including the steps of aspirating a fluid sample comprising magnetizable particles into a probe.
  • the probe has a top end that is opposite to an end of said probe for receiving a sample.
  • the probe is transported by the transport stage to a magnetic washing station.
  • the magnetic washing station has a first magnet for generating a first magnetic field and a second magnet for generating a second magnetic field.
  • the probe is moved in the magnetic washing station to a capture position, and then to a resuspend position.
  • the magnetizable particles are expelled from the probe.
  • the resuspend position is closer to the second magnet than the neutral position.
  • the lumen of the probe is flushed in the capture position with a diluent from a diluter assembly.
  • the diluent for flushing may be introduced at a second end of the probe and expelled at a first end of the probe.
  • the magnetizable particles are expelled into a container which may be a microtiter well.
  • the magnetizable particles are incubated with a body fluid and/or an immunoassay is performed.
  • FIG. 1 illustrates an embodiment of the device according to the invention.
  • FIGS. 2A-2D illustrates in cross-section, various embodiments of the probe according to the invention.
  • FIG. 3 illustrates one embodiment of the relative positioning of a first magnet to a second magnet in the magnetic washing station according to the invention.
  • FIGS. 4A-4D illustrate various positions of the probe as the probe is moved by the transport stage.
  • FIG. 5 is a graphic illustration of the relative force on a magnetizable bead as a function of the position of the bead between two magnets.
  • FIGS. 6A-6B illustrate the steps according to one embodiment of the invention for aspirating a sample with magnetizable beads into the probe.
  • FIG. 7 A illustrates one embodiment of the transport stage joined to the probe positioned in the sampling station.
  • FIG. 7B illustrates the transport stage joined to the probe positioned over the magnetic washing station.
  • FIG. 7C illustrates one embodiment of the probe in the neutral position of the magnetic washing station.
  • FIG. 7D illustrates one embodiment of the probe in the capture position of the magnetic washing station.
  • FIG. 7E illustrates one embodiment of the probe in the resuspend position of the magnetic washing station.
  • FIG. 7F illustrates one embodiment for dispensing the magnetizable particles from the probe reservoir through the probe sample end into a container.
  • FIG. 8 A illustrates the distribution of the magnetizable particles in the probe reservoir when the probe is in the neutral position in the magnetic washing station as viewed from the top of the magnetic washing station.
  • FIG. 8B illustrates the distribution of magnetizable particles when the probe is in the capture position in the magnetic washing station as viewed from the top of the magnetic washing station.
  • FIG. 8C illustrates the distribution of magnetizable particles when the probe is in the resuspend position in the magnetic washing station, as viewed from the top of the magnetic washing station.
  • FIG. 9 illustrates one embodiment of the probe according to the invention.
  • FIG. 10A illustrates one embodiment of a cross-section of the probe and the distribution of magnetizable particles in the probe reservoir when the probe is moved from the neutral position to the capture position in the magnetic washing station.
  • FIG. 10B illustrates the probe and the position of the magnetizable particles following a short dwell time in the capture position in the magnetic washing station.
  • FIG. 10C illustrates the probe and the position of the magnetizable particles when the dwell time of the probe in the capture position is longer than the dwell time of the probe in the capture position illustrated in FIG. 10B.
  • FIG. 11 A illustrates another embodiment of a cross-section of the probe and the distribution of the magnetizable particles in the probe reservoir when the probe is moved from the neutral position to the capture position in the magnetic washing probe.
  • FIG. 1 IB illustrates the probe and the position of the magnetizable particles following a short dwell time in the capture position in the magnetic washing station.
  • FIG. 11C illustrates the probe and the position of the magnetizable particles when the dwell time of the probe in the capture position is longer than the dwell time of the probe in the capture position illustrated in FIG. 1 IB.
  • the invention is a device, such as a clinical analytical instrument, including a washing probe for use in analyzing fluids, such as blood, in assays using magnetizable particles.
  • a transportable probe that has a reservoir for holding a fluid medium containing a plurality of magnetizable particles, at least two magnets, and a probe transport stage.
  • the probe is moveable by the transport stage in a plurality of positions with respect to at least one magnet.
  • the plurality of probe positions with respect to at least one magnet repositions the magnetizable particles in the probe reservoir between at least a capture position and a resuspend position.
  • the invention is a device having a probe that serves as a reservoir for washing, rinsing, or otherwise manipulating magnetizable particles, such as beads, in a fluid medium such as a suspension or a solution.
  • the device 6 includes a probe assembly 30, a sampling station 20 and a magnetic washing station 40.
  • the probe assembly 30 has a probe 10 in combination with a dilutor assembly 15, flexible tubing 25, and transport stage 35.
  • the probe 10, illustrated in FIG. 1 is generally a hollow tube having a top end 12, a sample end 14 opposite to the top end 12, a reservoir 16 extending along at least a portion of the length of the probe 10 from the top end 12 to the sample end 14, and at least one probe wall 18.
  • the probe 10 is substantially straight, rigid and has a round cross-section.
  • a cross-section of the probe 10 is polygonal and at least one wall of the probe 10 is flat.
  • a cross-section of the probe 10 is round, oval, or D-shaped.
  • the sample end 14 of the probe may terminate in a nozzle 17, illustrated in FIG. 1, having a cross-sectional diameter that is smaller than the reservoir 16 of the probe 10.
  • the nozzle 17 increases the velocity of the fluid expelled from the sample end 14 of the probe 10.
  • the shape of the probe 10 is not limited to those illustrated and may include other shapes.
  • the probe 10 may be manufactured from non-magnetic materials such as glass, plastic, ceramics, composite materials, metals, metal alloys, or other materials known to one skilled in the art.
  • the probe 10 may be manufactured from one material and clad in another material or may be made from multiple layers of the same material.
  • the dilutor assembly 15 is operatively joined to the top end 12 of the probe 10 by tubing 25, such as flexible tubing.
  • the dilutor assembly 15, for example, is a syringe pump with a rotary directional valve.
  • the dilutor assembly 15 pumps fluid such as a diluent or a wash fluid from a container (not shown) into the tubing 25, through the top end 12 of the probe 10, into the reservoir 16 of the probe 10, and dispenses the fluid out of the probe 10 through the sample end 14.
  • the syringe pump may be optionally ported via the flexible tubing 25 to the probe 10, or to a container of fluid (not shown) upstream from the probe 10.
  • the dilutor assembly 15 may also be an aspirator for aspirating fluid, for example, sample fluid such as body fluids, through the sample end 14 of the probe 10 into the reservoir 16 of the probe 10.
  • the tubing 25 connecting the dilutor assembly 15 to the probe 10 is manufactured from polytetrafiuoroethylene, rubber, polyvinylchloride, polyethylene, or other materials known in the art.
  • the probe assembly 30 further includes a transport stage 35 to which the probe 10 is joined.
  • the three axis transport stage 35 moves the probe 10 in a plurality of directions including at least bi-directional horizontal and bi-directional vertical movement.
  • the transport stage 35 may have a vertical motion that moves the probe 10 vertically, a horizontal motion that moves the probe 10 horizontally and/or a rotary motion that swings the probe 10 in an arc.
  • the magnetic washing station 40 has a plurality of magnets fixed in position relative to each other.
  • the magnetic washing station 40 has two permanent rectangular magnets 50, 51, i.e., a first magnet 50 generating a first magnetic field, and a second magnet 51 generating a second magnetic field.
  • the first magnet 50 and the second magnet 51 have different strengths and generate magnetic fields of unequal magnitude.
  • the first magnet 50 is stronger than the second magnet 51, i.e., the magnetic field generated by the first magnet 50 is greater in magnitude than the magnetic field generated by the second magnet 51.
  • the first magnet 50 may be 1 -5 times as strong as the second magnet 51, preferably 1-2 times as strong.
  • the magnets 50, 51 are mounted vertically and parallel to each other, with like poles of the magnets 50, 51 facing each other and separated by an air gap 53.
  • the gap 53 separating the first " magnet 50 from the second magnet 51 is in the range of one-sixteenth inch to 40 inches, in particular, 1.5 to 2.5 inches. In another embodiment, the gap 53 is determined to be 2.5 times to 1000 times the diameter of the probe 10.
  • the magnets 50, 51 are NeFeB magnets with magnetic faces 2.8 inches high and 0.5 inches wide.
  • the air gap indicated by arrow 53 between the face of the strong magnet 50 and the face of the weak magnet 51 is 1.95 inches.
  • the resultant flux density at any point on the central axis between the magnets is calculated as the algebraic sum of the flux densities from each individual magnet.
  • the transport stage 35 moves the probe 10 from a sample station (not shown) to a position above the magnetic washing station 40.
  • the probe 10 is lowered by the transport stage 35 to a neutral position 80 between the first magnet 50 and the second magnet 51.
  • the neutral position 80 is a position along a line drawn perpendicular to the face of the first magnet 50 and the face of the second magnet 51 where the resultant magnetic force on a magnetizable particle 100 is zero in the resultant magnetic field B generated by the first magnet 50 and the second magnet 51.
  • the neutral position 80 is a position of the probe 10 in the magnetic washing station where the probe 10 is closer to the weaker magnet 51, i.e., the magnet generating a weaker magnetic field, for example as shown in FIG. 4B, than to the stronger first magnet 50.
  • the transport stage 35 moves the probe 10 from the neutral position 80 to a capture position 60.
  • the capture position 60 is adjacent the stronger magnet 50 where the strength of the magnetic field of the first magnet 50 relative to the second magnet 51 is greatest.
  • the transport stage 35 moves the probe 10 from the capture position 60 to a resuspend position 70.
  • the probe 10 in the resuspend position 70 is closer to the second magnet 51 than is the probe 10 in the capture position 60 or the neutral position 80.
  • the force of the magnetic field generated by the second magnet 51 is greater than the force of the magnetic field on a magnetizable particle 100 in the probe 10 generated by the first magnet 50.
  • the overall force of the magnetic field is closer to zero in the resuspend position 70 than in the capture position 60.
  • the capture position 60 is 4.2 mm from the first magnet 50
  • the neutral position 80 is 22 mm from the second magnet 51
  • the resuspend position 70 is 14 mm from the second magnet 51.
  • the invention is a method for immobilizing and washing magnetizable beads 100 in, for example, an automated instrument for performing an immunoassay.
  • the probe 10 is positioned at the sampling station 20, illustrated in FIG. 6A, at a position external to the magnetic washing station 40, and the sample end 14 of the probe 10 is lowered into a container such as a well in a microtiter plate until the sample end 14 of the probe 10 meets a fluid sample containing magnetizable particles 100.
  • negative pressure generated by the dilutor assembly 15 causes an aliquot of fluid containing magnetizable particles 100 to be aspirated through the sample end 14 of the probe 10 and into the reservoir 16 of the probe 10.
  • the magnetizable particles 100 are made from a material that may be attracted to a magnet. Such materials include, for example, iron, iron oxide and other such materials known to the skilled person.
  • the particle 100 is a magnetizable latex particle having an iron oxide core surrounded by a polystyrene shell that is coated with a polymer bearing functional groups to which an antibody, or variants thereof, can be attached, for example, 280 nanometer DynabeadsTM M-280 Sheep anti Mouse IgG, (DYNAL, Inc., Lake Successful, New York).
  • the magnetizable particles 100 may be paramagnetic particles, typically 1-20 ⁇ m in size having a composition including ion oxides and various other materials, e.g., agarose or cellulose which may also have functional group, e.g., aminosilanes, for antibody attachment (Advanced Magnetics, Inc., Cambridge, Massachusetts).
  • the fluid in which the magnetizable particle 100 is suspended may be a body fluid, such as blood, containing an analyte of interest, a wash fluid a diluent, or a fluid containing a visualant such as fluorescein, rhodamine, gold particles, horseradish peroxidase, isoluminol, a labelled molecule such as a labelled antibody, an unlabelled antibody, variants thereof, or other compounds directed to the analyte of interest.
  • a body fluid such as blood, containing an analyte of interest, a wash fluid a diluent, or a fluid containing a visualant such as fluorescein, rhodamine, gold particles, horseradish peroxidase, isoluminol, a labelled molecule such as a labelled antibody, an unlabelled antibody, variants thereof, or other compounds directed to the analyte of interest.
  • the probe 10 holding the magnetizable particles 100 and the sample fluid in the probe reservoir 16 is moved by the transport stage 35 from the sampling station 20 , as indicated by arrow (a), to a position above the magnetic washing station 40, illustrated in FIG. 7B.
  • the transport stage 35 moves the probe 10 as indicated by the arrow (a) into the neutral position 80 of the magnetic washing station 40, illustrated in FIG. 7C, such that the probe reservoir 16 is positioned in the area between the first magnet 50 and the second magnet 51 and the sample end 14 of the probe 10 is substantially outside of the magnetic field generated by the first magnet 50 and the second magnet 51.
  • the calculated relative force on a magnetizable particle in a magnetic field B between magnet 50 and magnet 51 is proportional to BdelB, the product of the field strength times the field gradient.
  • BdelB the calculated relative force on a magnetizable particle 100 is graphically illustrated as a function of the neutral position 80 of the probe 10 in the magnetic washing station 40.
  • the relative force BdelB on a magnetizable particle 100 in the neutral position 80 is zero, i.e., the relative force of the resultant magnetic fields generated by the first magnet 50 and the second magnet 51 in the neutral position 80 does not favor movement of the magnetizable particle 100 toward the first magnet 50 or the second magnet 51.
  • the capture position 60 is adjacent the first magnet 50 when the magnetizable particles 100 are in the capture position 60, they are positioned in the magnetic field of greatest magnitude generated by the first magnet 50.
  • the calculated relative force on a magnetizable particle 100 is a function of the capture position 60 of the probe 10 in the magnetic washing station 40.
  • the relative force BdelB generated by the first magnet 50 and the second magnet 51 on a magnetizable particle in a position between the neutral position 80 and the capture position 60 favors movement of the magnetizable particle 100 in the direction of the first magnet 50.
  • FIG. 5 illustrates that the relative force BdelB in the (positive) direction of the first magnet 50 is maximal in the capture position 60.
  • the transport stage 35 joined to the probe 10 holding the magnetizable particles 100 in the probe reservoir 16 moves the probe 10 in a horizontal plane from the capture position 80 into the resuspend position 70.
  • the resuspend position 70 is closer to the second magnet 51 than the neutral position 80 or the capture position 60.
  • the calculated relative force on a magnetizable particle 100 is graphically illustrated as a function of the resuspend position 70 of the probe 10 in the magnetic washing station 40.
  • the relative force BdelB generated by the first magnet 50 and the second magnet 51 on a magnetizable particle 100 in a position between the neutral position 80 and the second magnet 51 favors movement of the magnetizable particle 100 in the direction of the second magnet 51.
  • FIG. 7E illustrates the resuspend position 70 is any position between the neutral position 80 and the second magnet 51 where the relative force BdelB is in the direction of the second magnet 51.
  • the dilutor assembly 15 expels the magnetizable particles 100 from the probe reservoir 16 through the sample end 14 of the probe 10 into a container.
  • FIGS. 8A-8C illustrate the distribution of the magnetizable particles 100 in the probe reservoir 16 when the probe 10 is in the probe neutral position 80, the probe capture position 60, and the probe resuspend position 70. Illustrated in FIG. 8 A, as viewed from the top of the probe 10, in the neutral position 80 the magnetizable particles 100 are distributed randomly in the fluid medium of the probe reservoir 16. Referring now to FIG. 8B, in the capture position 60, the magnetizable particles 100 move from their free random distribution in the probe neutral position, to an immobilized position on the inside of the wall 18 on the side of the probe 10 that is closest to the first magnet 50. Referring now to FIG.
  • the magnetizable particles 100 move away from their immobilized position on the side of the probe 10.
  • the magnetizable particles 100 move away from the wall 18 where the particles 100 were immobilized in the capture position 60, and become suspended and dispersed in the fluid medium of the probe reservoir 16.
  • the dwell time is brief enough to prevent the particles from being captured on the opposite side of the probe wall 18.
  • the invention described herein has several advantages over known devices that resort to steps that repeatedly expel and aspirate the magnetizable particle mixture in and out of the probe 10 through the probe sample end 14 in order to mix and resuspend the magnetizable particles 100 in the fluid medium.
  • the invention described herein minimizes the volume of fluid required to wash the magnetizable particles 100 because the particles 100 are resuspended in the wash fluid without requiring the step-by-step addition of successive volumes of wash fluid in order to flush the particles 100 from the probe lumen.
  • the washing step described herein is faster than washing steps that repeatedly expel and aspirate the magnetizable particle mixture in and out of the probe. Aerosolizing the wash fluid is also minimized according to the method of the invention because it is not necessary to forcefully expel the particles in the wash fluid from the probe in order to resuspend the particles. Minimizing aerosol is particularly important when body fluids which may harbor pathogens are sampled by the probe.
  • immobilization of the magnetizable particles 100 held within the probe reservoir 16 is accomplished by a tandem capture method.
  • the length of the reservoir 16 in probe 10, illustrated in FIG. 9, is the sum of the length of the first portion 11 of the probe reservoir 16 which corresponds to the height h of the first magnet 50, plus the length of the second portion 9 of the probe reservoir 16 which corresponds to the length of the probe reservoir 16 in excess of the length of the first portion 11.
  • magnetizable beads 100 are aspirated into and fill the length of the probe reservoir 16.
  • the probe reservoir is moved adjacent the first magnet 50 into the capture position 60.
  • the magnetizable beads 100 in the first portion 11 are in the magnetic field of the first magnet 50.
  • the magnetizable beads 100 in the first portion 11 of the probe reservoir 16 are immobilized by the magnetic field of the first magnet 50 on the inner wall of the first portion 11 of the probe reservoir 16.
  • the magnetizable beads 100 in the second portion 9 of the probe reservoir 16 are introduced by the dilutor assembly 15 from the second portion 9 into the first portion 11. Once the beads 100 from the second portion 9 are in the magnetic field of the first magnet 50, the beads 100 are immobilized on the im er wall 18 of the first portion 11 of the probe reservoir 16.
  • the shape of the probe 10 in cross-section may vary from round to polygonal.
  • the probe 10 has a round cross section as shown in FIGS. 10A- 10C.
  • the magnetizable particles 100 are randomly distributed in the probe reservoir 16 when the round probe 10 is in the neutral position 80, illustrated in FIG. 10A.
  • the magnetizable particles 100 tend to move toward the rectangular magnet 50 as indicated by the arrows shown in FIG. 10 A.
  • the magnetizable particles 100 accumulate on the portion of the inside circumference of the wall 18 that is closest to the first magnet 50, illustrated in FIG. 10B.
  • the magnetizable particles 100 tend to migrate to and aggregate at a point on the inside wall 18 of the probe 10 closest to the first magnet 50, as illustrated in FIG. IOC.
  • the probe 10 has a "D" shape cross-section as shown in FIGS. 11A-1 lC.
  • the wall 18 of the probe reservoir 16 closest to the rectangular magnet 50 is substantially flat, i.e., a cross section through the probe reservoir 16 is "D" shaped with the flat side of the "D" nearest the first magnet 50.
  • the magnetizable particles 100 are randomly distributed in the probe reservoir 16 when the probe 10 is in the neutral position 80, illustrated in FIG. 10A.
  • the magnetizable particles 100 tend to distribute uniformly across the inside flat surface of the wall 18 of the probe, illustrated in FIG. 1 IB. With increasing dwell time in the capture position 60, the magnetizable particles 100 tend to remain distributed relatively uniformly, as described above, on the inside wall 18 of the probe 10 closest to the rectangular magnet 50, illustrated in FIG. 1 lC.
  • the invention is a method for washing a magnetizable particle 100 used in an assay for detecting an analyte, such as in an immunoassay.
  • an antibody directed to the analyte of interest is bound to a magnetizable particle 100, such as a magnetizable bead, and mixed with an aliquot of a sample, such as blood.
  • the sample and magnetizable beads 100 are aspirated through the ⁇ sample end 14 of the probe 10 into the probe reservoir 16.
  • the probe 10 holding the sample and the magnetizable beads 100 is raised by the transport stage 35 and moved to the magnetic washing station 40 over the two magnets 50, 51.
  • the probe 10 is lowered by the transport stage 50 between the two magnets 50, 51 into the neutral position 80.
  • the probe 10 is then moved horizontally by the transport stage 35 into the capture position 60.
  • the magnetizable beads 100 bound to the antibody directed to the analyte of interest in the blood sample are immobilized in the probe reservoir 16 by the magnetic field of the first magnet 50.
  • a wash fluid is introduced by the dilutor assembly 15 through the tubing 25 and into the top 12 of the probe 10 and expelled through the sample end 14.
  • the probe is moved horizontally to the resuspend position 70 where the magnetizable beads 100 are resuspended and mixed in the fluid before the mixture containing the magnetizable particles 100 is expelled through the sample end 14 of the probe 100.
  • the probe 100 is moved by the transport stage 35 back to the sample station 20 to pick up another sample.

Abstract

An analytical instrument for the immobilization of antigens to be detected in an immunoassay using mangetizable beads. The instrument includes a probe containing magnetizable particles and a plurality of magnetic devices for applying a magnetic field gradient to the particles in the probe reservoir. The probe is movable between the plurality of magnetic devices and at least one of the probe positions may be used to immobilize the magnetic particles in the fluid medium and at least another position may be used to resuspend the particles in a fluid medium.

Description

IMMUNO ASSAY PROBE
Technical Field of the Invention
[0001] This invention relates to clinical diagnostic assays, in particular, immunoassays utilizing magnetizable particles and methods thereof.
Background of the Invention
[0002] Immunoassays, such as chemiluminescent immunoassays, generally require two antibody preparations, a first antibody used to capture and immobilize a target antigen molecule, and a second antibody used to attach a detection label to the antigen.
[0003] Immobilization of the antigen to be detected in an immunoassay may be accomplished using magnetizable beads, and detection may be accomplished by using a suitable visualant such as isoluminol chemiluminescence. The assay involves the following major steps. For example, a sample containing the antigen is mixed with a first antibody to the antigen which is coupled to magnetizable latex beads, and the mixture is allowed to react. A second antibody, typically to a different epitope on the antigen, coupled to isoluminol, is added to the sample in step 1 and the mixture is allowed to react. A magnetic field is applied to retain the magnetizable beads (with antigen bound, labeled antibody) against the inside wall of the container. A wash fluid is introduced to remove the unbound labeled antibody. Washing the magnetizable beads typically occurs by immobilizing the beads in the magnetic field, introducing a wash fluid, removing the magnetic field, and repeatedly expelling beads into and aspirating the beads from a container to recover all of the beads and to homogeneously mix and resuspend the beads in the wash fluid. The magnetizable beads with antigen bound, labeled antibody are resuspended in a suitable optical cuvette. An activating reagent such as hydrogen peroxide which activates isoluminol is added with the beads in the cuvette and light is emitted in a chemiluminescent reaction. The light emitted from the chemiluminescent reaction is detected using a suitable photodetector. For some applications, additional steps of reagent addition and/or washing may be necessary.
Summary of the Invention
[0004] The invention described herein features an analytical instrument including a probe with a reservoir, a dilutor assembly for introducing fluid containing magnetizable particles into the probe reservoir, and a plurality of magnetic devices for applying a magnetic field gradient to the particles in the probe reservoir. In one embodiment according to the invention, the analytical instrument has a magnetic washing station and a sampling station. The probe containing magnetic particles in the probe reservoir is moved into the magnetic washing station, that includes the magnets. The magnets include, for example, at least a first magnet and a second magnet, the second magnet having a magnetic field of different magnitude than the first magnet. Other magnetic devices are contemplated by the invention, such as one or more solenoid coils, and are not limited to the magnetic devices decried herein.
[0005] In one aspect, the invention includes a device for manipulating a magnetizable particle in a fluid medium. In one embodiment, according to the invention, the device may be used in an analytical instrument for determining the presence or measuring the quantity of an analyte in body fluids. The device includes a probe for holding and transporting the magnetizable particles and the probe is transportable to a plurality of positions. The device further includes a first magnet for generating a first magnetic field, and a second magnet for generating a second magnetic field. The probe is moveable in a plurality of probe positions between the first and second magnets. At least one of the probe positions immobilizes the magnetic particles in the fluid medium and at least another position resuspends the particles in a fluid medium. In one embodiment, the magnetizable beads are immobilized against an inner wall of the probe. The inner wall of the probe may be curved or flat.
[0006] In one embodiment, the magnitude of the first magnetic field is different than the magnitude of the second magnetic field. In a particular embodiment, the first magnet is in the range of about 1 to 5 times the strength of the second magnet. In a particular embodiment, the first magnet is in the range of about 1 to 2 times the strength of the second magnet. In yet another embodiment of the invention, the first magnet is separated from the second magnet by a gap in the range of about 1/16 inch to 40 inches, preferably, 1.5 to 2.5 inches, more preferably 1.95 inches.
[0007] In one embodiment there are three probe positions. The probe positions include a neutral position, an immobilizing position, and a resuspend position. In one embodiment the device has a transport stage for moving the probe between the plurality of probe positions. The transport stage may also move the probe between a sample station and a magnetic washing station. In a particular embodiment the probe has a thermal control element, and/or a liquid sensing element. [0008] In one embodiment according to the invention, the device has a dilutor assembly for introducing a fluid from a fluid reservoir into the probe reservoir through the top end of the probe. The top end of the probe is opposite to an end of the probe used for receiving a sample. In another embodiment, the dilutor assembly introduces fluid to the sample end of the probe.
[0010] In another aspect, the invention is a method for washing a magnetizable particle including the steps of aspirating a fluid sample comprising magnetizable particles into a probe. The probe has a top end that is opposite to an end of said probe for receiving a sample. The probe is transported by the transport stage to a magnetic washing station. The magnetic washing station has a first magnet for generating a first magnetic field and a second magnet for generating a second magnetic field. The probe is moved in the magnetic washing station to a capture position, and then to a resuspend position. The magnetizable particles are expelled from the probe. In yet another embodiment of the invention, the resuspend position is closer to the second magnet than the neutral position.
[0011] In one embodiment according to the invention, the lumen of the probe is flushed in the capture position with a diluent from a diluter assembly. The diluent for flushing may be introduced at a second end of the probe and expelled at a first end of the probe.
[0012] In one embodiment according to the invention, the magnetizable particles are expelled into a container which may be a microtiter well.
[0013] In another aspect, the magnetizable particles are incubated with a body fluid and/or an immunoassay is performed.
[0014] These and other objects, along with advantages and features of the present invention herein disclosed, will become apparent through reference to the following description, the accompanying drawings and the claims. Furthermore, it is to be understood that the features of the various embodiments described herein are not mutually exclusive and can exist in various combinations and permutations.
Brief Description of the Figures
[0015] The foregoing and other objects, features and advantages of the present invention disclosed herein, as well as the invention itself, will be more fully understood from the following description of preferred embodiments and claims, when read together with the accompanying drawings. The drawings are not to drawn to scale and emphasis instead is generally being placed upon illustrating the principles of the invention. [0016] FIG. 1 illustrates an embodiment of the device according to the invention.
[0017] FIGS. 2A-2D illustrates in cross-section, various embodiments of the probe according to the invention.
[0018] FIG. 3 illustrates one embodiment of the relative positioning of a first magnet to a second magnet in the magnetic washing station according to the invention.
[0019] FIGS. 4A-4D illustrate various positions of the probe as the probe is moved by the transport stage.
[0020] FIG. 5 is a graphic illustration of the relative force on a magnetizable bead as a function of the position of the bead between two magnets.
[0021] FIGS. 6A-6B illustrate the steps according to one embodiment of the invention for aspirating a sample with magnetizable beads into the probe.
[0022] FIG. 7 A illustrates one embodiment of the transport stage joined to the probe positioned in the sampling station.
[0023] FIG. 7B illustrates the transport stage joined to the probe positioned over the magnetic washing station.
[0024] FIG. 7C illustrates one embodiment of the probe in the neutral position of the magnetic washing station.
[0025] FIG. 7D illustrates one embodiment of the probe in the capture position of the magnetic washing station.
[0026] FIG. 7E illustrates one embodiment of the probe in the resuspend position of the magnetic washing station.
[0027] FIG. 7F illustrates one embodiment for dispensing the magnetizable particles from the probe reservoir through the probe sample end into a container.
[0028] FIG. 8 A illustrates the distribution of the magnetizable particles in the probe reservoir when the probe is in the neutral position in the magnetic washing station as viewed from the top of the magnetic washing station.
[0029] FIG. 8B illustrates the distribution of magnetizable particles when the probe is in the capture position in the magnetic washing station as viewed from the top of the magnetic washing station. [0030] FIG. 8C illustrates the distribution of magnetizable particles when the probe is in the resuspend position in the magnetic washing station, as viewed from the top of the magnetic washing station.
[0031] FIG. 9 illustrates one embodiment of the probe according to the invention.
[0032] FIG. 10A illustrates one embodiment of a cross-section of the probe and the distribution of magnetizable particles in the probe reservoir when the probe is moved from the neutral position to the capture position in the magnetic washing station.
[0033] FIG. 10B illustrates the probe and the position of the magnetizable particles following a short dwell time in the capture position in the magnetic washing station.
[0034] FIG. 10C illustrates the probe and the position of the magnetizable particles when the dwell time of the probe in the capture position is longer than the dwell time of the probe in the capture position illustrated in FIG. 10B.
[0035] FIG. 11 A illustrates another embodiment of a cross-section of the probe and the distribution of the magnetizable particles in the probe reservoir when the probe is moved from the neutral position to the capture position in the magnetic washing probe.
[0036] FIG. 1 IB illustrates the probe and the position of the magnetizable particles following a short dwell time in the capture position in the magnetic washing station.
[0037] FIG. 11C illustrates the probe and the position of the magnetizable particles when the dwell time of the probe in the capture position is longer than the dwell time of the probe in the capture position illustrated in FIG. 1 IB.
Description of the Invention
[0038] The invention, described herein, is a device, such as a clinical analytical instrument, including a washing probe for use in analyzing fluids, such as blood, in assays using magnetizable particles. The embodiments of the invention described below have the following common features, a transportable probe that has a reservoir for holding a fluid medium containing a plurality of magnetizable particles, at least two magnets, and a probe transport stage. The probe is moveable by the transport stage in a plurality of positions with respect to at least one magnet. The plurality of probe positions with respect to at least one magnet repositions the magnetizable particles in the probe reservoir between at least a capture position and a resuspend position. [0039] In general, the invention is a device having a probe that serves as a reservoir for washing, rinsing, or otherwise manipulating magnetizable particles, such as beads, in a fluid medium such as a suspension or a solution.
[0040] Referring to FIG. 1, in one embodiment according to the invention, the device 6 includes a probe assembly 30, a sampling station 20 and a magnetic washing station 40. The probe assembly 30 has a probe 10 in combination with a dilutor assembly 15, flexible tubing 25, and transport stage 35. The probe 10, illustrated in FIG. 1, is generally a hollow tube having a top end 12, a sample end 14 opposite to the top end 12, a reservoir 16 extending along at least a portion of the length of the probe 10 from the top end 12 to the sample end 14, and at least one probe wall 18. In one embodiment, the probe 10 is substantially straight, rigid and has a round cross-section. In another embodiment according to the invention, for example, illustrated in FIG. 2 A, a cross-section of the probe 10 is polygonal and at least one wall of the probe 10 is flat. In yet another embodiment according to the invention, illustrated in FIGS. 2B-2D, a cross-section of the probe 10 is round, oval, or D-shaped.
[0041] In a particular embodiment of the probe 10 according to the invention, the sample end 14 of the probe may terminate in a nozzle 17, illustrated in FIG. 1, having a cross-sectional diameter that is smaller than the reservoir 16 of the probe 10. The nozzle 17 increases the velocity of the fluid expelled from the sample end 14 of the probe 10. The shape of the probe 10 is not limited to those illustrated and may include other shapes. The probe 10 may be manufactured from non-magnetic materials such as glass, plastic, ceramics, composite materials, metals, metal alloys, or other materials known to one skilled in the art. The probe 10 may be manufactured from one material and clad in another material or may be made from multiple layers of the same material.
[0042] Referring still to FIG. 1, the dilutor assembly 15 is operatively joined to the top end 12 of the probe 10 by tubing 25, such as flexible tubing. In one embodiment, the dilutor assembly 15, for example, is a syringe pump with a rotary directional valve. The dilutor assembly 15 pumps fluid such as a diluent or a wash fluid from a container (not shown) into the tubing 25, through the top end 12 of the probe 10, into the reservoir 16 of the probe 10, and dispenses the fluid out of the probe 10 through the sample end 14. The syringe pump may be optionally ported via the flexible tubing 25 to the probe 10, or to a container of fluid (not shown) upstream from the probe 10. The dilutor assembly 15 may also be an aspirator for aspirating fluid, for example, sample fluid such as body fluids, through the sample end 14 of the probe 10 into the reservoir 16 of the probe 10.
[0043] The tubing 25 connecting the dilutor assembly 15 to the probe 10 is manufactured from polytetrafiuoroethylene, rubber, polyvinylchloride, polyethylene, or other materials known in the art.
[0044] With continued reference to FIG. 1, the probe assembly 30 further includes a transport stage 35 to which the probe 10 is joined. The three axis transport stage 35 moves the probe 10 in a plurality of directions including at least bi-directional horizontal and bi-directional vertical movement.
[0045] Alternatively, the transport stage 35 may have a vertical motion that moves the probe 10 vertically, a horizontal motion that moves the probe 10 horizontally and/or a rotary motion that swings the probe 10 in an arc.
[0046] Referring now to FIG. 3, the magnetic washing station 40 has a plurality of magnets fixed in position relative to each other. In a particular embodiment, the magnetic washing station 40 has two permanent rectangular magnets 50, 51, i.e., a first magnet 50 generating a first magnetic field, and a second magnet 51 generating a second magnetic field. In a particular embodiment of the invention, the first magnet 50 and the second magnet 51 have different strengths and generate magnetic fields of unequal magnitude. In one embodiment according to the invention, the first magnet 50 is stronger than the second magnet 51, i.e., the magnetic field generated by the first magnet 50 is greater in magnitude than the magnetic field generated by the second magnet 51. For example, the first magnet 50 may be 1 -5 times as strong as the second magnet 51, preferably 1-2 times as strong. In a particular embodiment, referring still to FIG. 3, the magnets 50, 51 are mounted vertically and parallel to each other, with like poles of the magnets 50, 51 facing each other and separated by an air gap 53. The gap 53 separating the first" magnet 50 from the second magnet 51 is in the range of one-sixteenth inch to 40 inches, in particular, 1.5 to 2.5 inches. In another embodiment, the gap 53 is determined to be 2.5 times to 1000 times the diameter of the probe 10.
[0047] In one embodiment according to the invention, the magnets 50, 51 are NeFeB magnets with magnetic faces 2.8 inches high and 0.5 inches wide. The stronger or first magnet 50 is the capture or immobilizing magnet and is about 1 inch thick along the direction of magnetization, and has remanence Br = 13.1 kG. The weaker or second magnet 51 is the resuspend magnet and is about 0.2 inches thick along the direction of magnetization and has remanence Br = 11.4kG. In this embodiment, the air gap indicated by arrow 53 between the face of the strong magnet 50 and the face of the weak magnet 51 is 1.95 inches.
[0048] The flux density Bx a distance X from the face of a rectangular magnet of remanance Br, length L in the direction of magnetization, and face dimension A by B, is given by
Figure imgf000009_0001
[0049] For magnets 50 and 51 arranged as described above with like poles facing each other so that the magnetic forces from the two magnets are opposed in direction, the resultant flux density at any point on the central axis between the magnets is calculated as the algebraic sum of the flux densities from each individual magnet.
[0050] According to one embodiment of the invention, illustrated in FIG. 4 A, the transport stage 35 moves the probe 10 from a sample station (not shown) to a position above the magnetic washing station 40. Referring now to FIG. 4B, the probe 10 is lowered by the transport stage 35 to a neutral position 80 between the first magnet 50 and the second magnet 51. The neutral position 80 is a position along a line drawn perpendicular to the face of the first magnet 50 and the face of the second magnet 51 where the resultant magnetic force on a magnetizable particle 100 is zero in the resultant magnetic field B generated by the first magnet 50 and the second magnet 51. As illustrated in FIG. 4B, the neutral position 80 is a position of the probe 10 in the magnetic washing station where the probe 10 is closer to the weaker magnet 51, i.e., the magnet generating a weaker magnetic field, for example as shown in FIG. 4B, than to the stronger first magnet 50.
[0051] In one embodiment of the invention, illustrated in FIG. 4C, the transport stage 35 moves the probe 10 from the neutral position 80 to a capture position 60. The capture position 60 is adjacent the stronger magnet 50 where the strength of the magnetic field of the first magnet 50 relative to the second magnet 51 is greatest. In another embodiment of the invention illustrated in FIG. 4D, the transport stage 35 moves the probe 10 from the capture position 60 to a resuspend position 70. The probe 10 in the resuspend position 70 is closer to the second magnet 51 than is the probe 10 in the capture position 60 or the neutral position 80. In the resuspend position 70, the force of the magnetic field generated by the second magnet 51 is greater than the force of the magnetic field on a magnetizable particle 100 in the probe 10 generated by the first magnet 50. The overall force of the magnetic field is closer to zero in the resuspend position 70 than in the capture position 60.
[0052] In a particular embodiment according to the invention, the capture position 60 is 4.2 mm from the first magnet 50, the neutral position 80 is 22 mm from the second magnet 51, and the resuspend position 70 is 14 mm from the second magnet 51.
[0053] In another aspect, the invention is a method for immobilizing and washing magnetizable beads 100 in, for example, an automated instrument for performing an immunoassay. In one embodiment according to this aspect of the invention, the probe 10 is positioned at the sampling station 20, illustrated in FIG. 6A, at a position external to the magnetic washing station 40, and the sample end 14 of the probe 10 is lowered into a container such as a well in a microtiter plate until the sample end 14 of the probe 10 meets a fluid sample containing magnetizable particles 100. Referring now to FIG. 6B, in one embodiment according to this aspect of the invention, negative pressure generated by the dilutor assembly 15 causes an aliquot of fluid containing magnetizable particles 100 to be aspirated through the sample end 14 of the probe 10 and into the reservoir 16 of the probe 10. The magnetizable particles 100 are made from a material that may be attracted to a magnet. Such materials include, for example, iron, iron oxide and other such materials known to the skilled person. In a particular embodiment, the particle 100 is a magnetizable latex particle having an iron oxide core surrounded by a polystyrene shell that is coated with a polymer bearing functional groups to which an antibody, or variants thereof, can be attached, for example, 280 nanometer Dynabeads™ M-280 Sheep anti Mouse IgG, (DYNAL, Inc., Lake Successful, New York). Alternatively, the magnetizable particles 100 may be paramagnetic particles, typically 1-20 μm in size having a composition including ion oxides and various other materials, e.g., agarose or cellulose which may also have functional group, e.g., aminosilanes, for antibody attachment (Advanced Magnetics, Inc., Cambridge, Massachusetts). The fluid in which the magnetizable particle 100 is suspended may be a body fluid, such as blood, containing an analyte of interest, a wash fluid a diluent, or a fluid containing a visualant such as fluorescein, rhodamine, gold particles, horseradish peroxidase, isoluminol, a labelled molecule such as a labelled antibody, an unlabelled antibody, variants thereof, or other compounds directed to the analyte of interest.
Probe positions and the relative force BdelB on the magnetizable particles
[0054] In one embodiment of the invention referring to FIG. 7 A, the probe 10 holding the magnetizable particles 100 and the sample fluid in the probe reservoir 16 is moved by the transport stage 35 from the sampling station 20 , as indicated by arrow (a), to a position above the magnetic washing station 40, illustrated in FIG. 7B. Referring to FIG. 7B, the transport stage 35 moves the probe 10 as indicated by the arrow (a) into the neutral position 80 of the magnetic washing station 40, illustrated in FIG. 7C, such that the probe reservoir 16 is positioned in the area between the first magnet 50 and the second magnet 51 and the sample end 14 of the probe 10 is substantially outside of the magnetic field generated by the first magnet 50 and the second magnet 51.
[0055] The calculated relative force on a magnetizable particle in a magnetic field B between magnet 50 and magnet 51 is proportional to BdelB, the product of the field strength times the field gradient. Referring to FIG. 5, the calculated relative force on a magnetizable particle 100 is graphically illustrated as a function of the neutral position 80 of the probe 10 in the magnetic washing station 40. The relative force BdelB on a magnetizable particle 100 in the neutral position 80 is zero, i.e., the relative force of the resultant magnetic fields generated by the first magnet 50 and the second magnet 51 in the neutral position 80 does not favor movement of the magnetizable particle 100 toward the first magnet 50 or the second magnet 51.
[0056] Referring again to FIG. 7C, the transport stage 35 joined to the probe 10 holding the magnetizable particles 100 in the probe reservoir 16, moves the probe 10 in a horizontal plane as indicated by arrow (a) from the neutral position 80 into the capture position 60. Referring now to FIG. 7D, the capture position 60 is adjacent the first magnet 50 when the magnetizable particles 100 are in the capture position 60, they are positioned in the magnetic field of greatest magnitude generated by the first magnet 50.
[0057] Referring again to the graph in FIG. 5, in the capture position 60 the calculated relative force on a magnetizable particle 100 is a function of the capture position 60 of the probe 10 in the magnetic washing station 40. The relative force BdelB generated by the first magnet 50 and the second magnet 51 on a magnetizable particle in a position between the neutral position 80 and the capture position 60 favors movement of the magnetizable particle 100 in the direction of the first magnet 50. FIG. 5 illustrates that the relative force BdelB in the (positive) direction of the first magnet 50 is maximal in the capture position 60.
[0058] Referring now to FIG. 7E, in one embodiment according to the invention, the transport stage 35 joined to the probe 10 holding the magnetizable particles 100 in the probe reservoir 16, moves the probe 10 in a horizontal plane from the capture position 80 into the resuspend position 70. The resuspend position 70 is closer to the second magnet 51 than the neutral position 80 or the capture position 60.
[0059] Referring again to FIG. 5, in the capture position 60 the calculated relative force on a magnetizable particle 100 is graphically illustrated as a function of the resuspend position 70 of the probe 10 in the magnetic washing station 40. The relative force BdelB generated by the first magnet 50 and the second magnet 51 on a magnetizable particle 100 in a position between the neutral position 80 and the second magnet 51 favors movement of the magnetizable particle 100 in the direction of the second magnet 51. FIG. 7E illustrates the resuspend position 70 is any position between the neutral position 80 and the second magnet 51 where the relative force BdelB is in the direction of the second magnet 51.
[0060] Referring now to FIG. 7F, in one embodiment according to the invention, while the probe 10 is in the resuspend position 70, the dilutor assembly 15 expels the magnetizable particles 100 from the probe reservoir 16 through the sample end 14 of the probe 10 into a container.
The effect of BdelB in the positions of the probe on the distribution of the magnetizable particles in the probe reservoir
[0061] FIGS. 8A-8C illustrate the distribution of the magnetizable particles 100 in the probe reservoir 16 when the probe 10 is in the probe neutral position 80, the probe capture position 60, and the probe resuspend position 70. Illustrated in FIG. 8 A, as viewed from the top of the probe 10, in the neutral position 80 the magnetizable particles 100 are distributed randomly in the fluid medium of the probe reservoir 16. Referring now to FIG. 8B, in the capture position 60, the magnetizable particles 100 move from their free random distribution in the probe neutral position, to an immobilized position on the inside of the wall 18 on the side of the probe 10 that is closest to the first magnet 50. Referring now to FIG. 8C, in the resuspend position 70, the magnetizable particles 100 move away from their immobilized position on the side of the probe 10. With increasing dwell time in the resuspend position 70, the magnetizable particles 100 move away from the wall 18 where the particles 100 were immobilized in the capture position 60, and become suspended and dispersed in the fluid medium of the probe reservoir 16. The dwell time is brief enough to prevent the particles from being captured on the opposite side of the probe wall 18. Thus, by applying a magnetic force to actively move the immobilized magnetizable particles 100 away from the wall 18 of the probe 10, the invention described herein has several advantages over known devices that resort to steps that repeatedly expel and aspirate the magnetizable particle mixture in and out of the probe 10 through the probe sample end 14 in order to mix and resuspend the magnetizable particles 100 in the fluid medium. For example, the invention described herein minimizes the volume of fluid required to wash the magnetizable particles 100 because the particles 100 are resuspended in the wash fluid without requiring the step-by-step addition of successive volumes of wash fluid in order to flush the particles 100 from the probe lumen. The washing step described herein is faster than washing steps that repeatedly expel and aspirate the magnetizable particle mixture in and out of the probe. Aerosolizing the wash fluid is also minimized according to the method of the invention because it is not necessary to forcefully expel the particles in the wash fluid from the probe in order to resuspend the particles. Minimizing aerosol is particularly important when body fluids which may harbor pathogens are sampled by the probe.
[0062] In yet another embodiment according to the invention, immobilization of the magnetizable particles 100 held within the probe reservoir 16 is accomplished by a tandem capture method. In this embodiment, the length of the reservoir 16 in probe 10, illustrated in FIG. 9, is the sum of the length of the first portion 11 of the probe reservoir 16 which corresponds to the height h of the first magnet 50, plus the length of the second portion 9 of the probe reservoir 16 which corresponds to the length of the probe reservoir 16 in excess of the length of the first portion 11.
[0063] In the tandem capture method, magnetizable beads 100 are aspirated into and fill the length of the probe reservoir 16. The probe reservoir is moved adjacent the first magnet 50 into the capture position 60. The magnetizable beads 100 in the first portion 11 are in the magnetic field of the first magnet 50. The magnetizable beads 100 in the first portion 11 of the probe reservoir 16 are immobilized by the magnetic field of the first magnet 50 on the inner wall of the first portion 11 of the probe reservoir 16. The magnetizable beads 100 in the second portion 9 of the probe reservoir 16 are introduced by the dilutor assembly 15 from the second portion 9 into the first portion 11. Once the beads 100 from the second portion 9 are in the magnetic field of the first magnet 50, the beads 100 are immobilized on the im er wall 18 of the first portion 11 of the probe reservoir 16.
The effect of probe shape on distribution of the magnetizable particles in the capture position
[0064] The shape of the probe 10 in cross-section may vary from round to polygonal. In one embodiment of the invention, the probe 10 has a round cross section as shown in FIGS. 10A- 10C. The magnetizable particles 100 are randomly distributed in the probe reservoir 16 when the round probe 10 is in the neutral position 80, illustrated in FIG. 10A. When the round probe 10 is moved from the neutral position 80 to the capture position 60, the magnetizable particles 100 tend to move toward the rectangular magnet 50 as indicated by the arrows shown in FIG. 10 A. Accordingly, the magnetizable particles 100 accumulate on the portion of the inside circumference of the wall 18 that is closest to the first magnet 50, illustrated in FIG. 10B. With increasing dwell time in the capture position 60, the magnetizable particles 100 tend to migrate to and aggregate at a point on the inside wall 18 of the probe 10 closest to the first magnet 50, as illustrated in FIG. IOC.
[0065] In another embodiment according to the invention, the probe 10 has a "D" shape cross-section as shown in FIGS. 11A-1 lC. In a particular embodiment, illustrated, for example, in FIG. 11 A, the wall 18 of the probe reservoir 16 closest to the rectangular magnet 50 is substantially flat, i.e., a cross section through the probe reservoir 16 is "D" shaped with the flat side of the "D" nearest the first magnet 50. With a "D" shape probe 10, the magnetizable particles 100 are randomly distributed in the probe reservoir 16 when the probe 10 is in the neutral position 80, illustrated in FIG. 10A. When the "D" shaped probe 10 is moved from the neutral position 80 to the capture position 60, the magnetizable particles 100 tend to distribute uniformly across the inside flat surface of the wall 18 of the probe, illustrated in FIG. 1 IB. With increasing dwell time in the capture position 60, the magnetizable particles 100 tend to remain distributed relatively uniformly, as described above, on the inside wall 18 of the probe 10 closest to the rectangular magnet 50, illustrated in FIG. 1 lC.
The washing step in the capture position
[0066] In one aspect, the invention is a method for washing a magnetizable particle 100 used in an assay for detecting an analyte, such as in an immunoassay. In one embodiment, an antibody directed to the analyte of interest is bound to a magnetizable particle 100, such as a magnetizable bead, and mixed with an aliquot of a sample, such as blood. In the sample station 20, the sample and magnetizable beads 100 are aspirated through the\sample end 14 of the probe 10 into the probe reservoir 16. The probe 10 holding the sample and the magnetizable beads 100 is raised by the transport stage 35 and moved to the magnetic washing station 40 over the two magnets 50, 51. The probe 10 is lowered by the transport stage 50 between the two magnets 50, 51 into the neutral position 80. The probe 10 is then moved horizontally by the transport stage 35 into the capture position 60. The magnetizable beads 100 bound to the antibody directed to the analyte of interest in the blood sample are immobilized in the probe reservoir 16 by the magnetic field of the first magnet 50. A wash fluid is introduced by the dilutor assembly 15 through the tubing 25 and into the top 12 of the probe 10 and expelled through the sample end 14. The probe is moved horizontally to the resuspend position 70 where the magnetizable beads 100 are resuspended and mixed in the fluid before the mixture containing the magnetizable particles 100 is expelled through the sample end 14 of the probe 100. The probe 100 is moved by the transport stage 35 back to the sample station 20 to pick up another sample.
[0067] The direction of movement of the probe in each step of the method is intended to be exemplary and not limited to only that which is specifically recited.
[0068] Changes and modification may be made to the invention without departing from the scope and spirit of the invention. Accordingly, the particular combinations of parts described and illustrated herein is intended to represent only an illustrative embodiment of the invention, and is not intended to serve as limitations of alternative embodiments.
What is claimed is:

Claims

1. A device for manipulating a magnetizable particle in a solution, comprising: a probe for holding and transporting said magnetizable particles, said probe is transportable in a plurality of positions; a first magnet for generating a first magnetic field; and a second magnet for generating a second magnetic field, wherein said plurality of probe positions comprises positions between said first and second magnets.
2. The device according to claim 1 wherein at least one of said probe positions immobilizes said magnetizable particles in said solution, and at least another one of said positions resuspends said particles in said solution.
3. The device according to claim 1 wherein said probe comprises an inner wall and said magnetizable particles are immobilized against the inner wall of said probe.
4. The device according to claim 3 wherein said inner wall comprises a flat surface.
5. The device of claim 1 wherein the magnitude of said first magnetic field is different than the magnitude of said second magnetic field.
6. The device according to claim 1 wherein said plurality of probe positions comprises three positions.
7. The device according to claim 6 wherein one of said probe positions comprises a resuspend position.
8. The device according to claim 1 further comprising a transport stage for transporting said probe.
9. The device according to claim 1 further comprising a dilutor assembly, wherein ! said dilutor assembly introduces a fluid into a top end of the probe, and wherein the top end of i the probe is opposite to an end of said probe for receiving a sample.
10. The device according to claim 1 wherein said probe further comprises a thermal control element.
11. The device according to claim 1 wherein said probe further comprises a liquid level sensing element.
12. The device according to claim 1 wherein said first magnet is in the range of about 1.0 to 5.0 times the strength of the second magnet.
13. The device according to claim 1 wherein the first magnet and the second magnet are separated by a gap in the range of about 1.5 to 2.5 inches.
14. The device according to claim 1 wherein the strength of the first magnet is in the range of about 1.0-2.0 times the strength of the second magnet.
15. The device according to claim 1 wherein the first magnet and the second magnet are separated by a gap of about 1.95 inches.
16. The device according to claim 9 wherein said dilutor assembly introduces fluid to a receiving end of said probe.
17. A method for washing a magnetizable particle, comprising the steps of: aspirating a fluid sample comprising magnetizable particles into a probe, wherein said probe is transportable to a plurality of positions and joined to a transportation stage; transporting said probe joined to said transporting stage to a magnetic washing station, said magnetic washing station comprising a first magnet for generating a first magnetic field and a second magnet for generating a second magnetic field and washing said magnetizable particle.
18. The method of claim 17 further comprising the steps of: moving said probe to a capture position; moving said probe from said capture position to a resuspend position; and expelling said magnetizable particles from said probe.
19. The method of claim 18 further comprising: moving said probe from a resuspend position to a neutral position; and transporting said probe away from said magnetic washing station.
20. The method of claim 18 further comprising the step of flushing the lumen of said probe in said capture position with a diluent from a dilutor assembly.
21. The method of claim 20 wherein said diluent for flushing is introduced at a second end of said probe and expelled at a first end of said probe.
22. The method of claim 17 wherein said magnetizable particles are aspirated from a container.
23. The method of claim 22 wherein said container is a microtiter well.
] 24. The method of claim 18 wherein said magnetizable particles are expelled into a container.
25. The method of claim 24 wherein said container is a microtiter well.
26. The method of claim 17 further comprising the step of incubating said magnetizable particles with a body fluid.
27. The method of claim 17 further comprising the step of performing an immunoassay.
28. The method of claim 18 wherein said resuspend position is closer to said second magnet than said neutral position.
29. A method for manipulating a magnetizable particle in a solution, comprising the steps of: introducing said particles into a probe; immobilizing said particles in said probe by a first magnetic field; and resuspending said particles in said probe by a second magnetic field.
PCT/US2003/011157 2002-04-12 2003-04-10 Immunoassay probe WO2003086637A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP03746724A EP1494814A1 (en) 2002-04-12 2003-04-10 Immunoassay probe
AU2003226075A AU2003226075B2 (en) 2002-04-12 2003-04-10 Immunoassay probe
CA002481545A CA2481545A1 (en) 2002-04-12 2003-04-10 Immunoassay probe
JP2003583638A JP2005522679A (en) 2002-04-12 2003-04-10 Immunoassay probe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37233102P 2002-04-12 2002-04-12
US60/372,331 2002-04-12

Publications (1)

Publication Number Publication Date
WO2003086637A1 true WO2003086637A1 (en) 2003-10-23

Family

ID=29250838

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/011157 WO2003086637A1 (en) 2002-04-12 2003-04-10 Immunoassay probe

Country Status (6)

Country Link
US (1) US7514270B2 (en)
EP (1) EP1494814A1 (en)
JP (1) JP2005522679A (en)
AU (1) AU2003226075B2 (en)
CA (1) CA2481545A1 (en)
WO (1) WO2003086637A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008075287A2 (en) * 2006-12-20 2008-06-26 Philips Intellectual Property & Standards Gmbh Method and arrangement for separating magnetic particles, magnetic particles and use magnetic particles
US7731899B2 (en) 2007-02-08 2010-06-08 Biokit, S.A. Apparatus and methods for dispensing sample holders
EP2208531A1 (en) 2008-12-30 2010-07-21 Atonomics A/S Distribution of particles in capillary channel by application of magnetic field

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070207272A1 (en) * 2006-03-03 2007-09-06 Puri Ishwar K Method and apparatus for magnetic mixing in micron size droplets
US20080188176A1 (en) * 2007-02-07 2008-08-07 Hunt John W Roof vent shield
DE102007039899B3 (en) * 2007-08-23 2009-04-09 Siemens Ag Sensor for enabling the detection of a substance in the body of a living being
US20110097240A1 (en) * 2008-06-12 2011-04-28 Hitachi High-Technologies Corporation Analyzer using magnetic particles
US10072927B2 (en) 2016-01-07 2018-09-11 Rarecyte, Inc. Detecting a substrate
US11054346B2 (en) * 2013-04-11 2021-07-06 Rarecyte, Inc. Detecting a substrate
US10416046B2 (en) * 2013-04-11 2019-09-17 Rarecyte, Inc. Device, system, and method for selecting a target analyte
CN117031013A (en) 2015-03-10 2023-11-10 西门子医疗保健诊断公司 Quantification of functional groups on solid support
CN113376370A (en) * 2020-03-09 2021-09-10 陈琪 Method and device for separating magnetic particles

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681478A (en) * 1989-12-07 1997-10-28 Diatec Instruments A/S Method and apparatus for magnetically separating and resuspending super-paramagnetic particles in a solution
US6143578A (en) * 1996-05-10 2000-11-07 Bayer Corporation Method and apparatus for wash, resuspension, recollection and localization of magnetizable particles in assays using magnetic separation technology
US20010007312A1 (en) * 1995-02-21 2001-07-12 Siddiqi Iqbal W. Apparatus and method for mixing and separation employing magnetic particles

Family Cites Families (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952599A (en) 1972-05-18 1976-04-27 Ayres Waldemar A Fractional-fill capillary pipette and method
FI55093C (en) 1974-07-05 1979-05-10 Osmo Antero Suovaniemi FOERFARANDE FOER EXAKT MAETNING AV ABSORPTION AV SMAO VAETSKEMAENGDER SAMT ANORDNING FOER DESS GENOMFOERANDE
SE380099B (en) 1974-02-07 1975-10-27 Monega Anstalt
DE2422260B2 (en) 1974-05-08 1979-04-12 Compur-Electronic Gmbh, 8000 Muenchen Device for the production of a measuring liquid to be optically examined
SE381577B (en) 1974-06-24 1975-12-15 Mediplast Ab DEVICE FOR TRANSFERRING A LIQUID, AS BLOOD FROM A CYLINDRICAL CONTAINER TO A PIPETTE
US3939834A (en) 1974-09-24 1976-02-24 Mcmahon Patrick J Metal coated articles
US3985649A (en) 1974-11-25 1976-10-12 Eddelman Roy T Ferromagnetic separation process and material
SE389972B (en) 1975-03-27 1976-11-29 Autochem Instrument Ab DEVICE FOR DOSING A LIQUID INTO A PROVER AND FOR AGITATING THE CONTENTS OF THE PROVER
US4067776A (en) 1975-11-25 1978-01-10 Research Foundation Of Children's Hospital Method for differential diagnosis of meningitis with a limulus lysate test
GB1575805A (en) 1976-03-12 1980-10-01 Technicon Instr Automatic diagnostic apparatus
US4022577A (en) 1976-03-12 1977-05-10 The University Of Virginia Automated radioimmunoassay
US4292920A (en) 1976-04-26 1981-10-06 Smith Kendall O Magnetic attraction transfer devices for use in solid phase radioimmunoassays and in other assay methods
GB1581541A (en) 1976-06-18 1980-12-17 Unilever Ltd Cheese
US4066407A (en) 1976-12-16 1978-01-03 Vincent Lupica Body fluid testing system and process
US4275591A (en) 1977-07-25 1981-06-30 Becton, Dickinson And Company Protective shield for capillary pipette
US4195526A (en) 1978-02-09 1980-04-01 Corning Glass Works Hand-held pipetter
US4783250A (en) 1979-08-21 1988-11-08 Pons B Stanley Immobilized electrochemical cell devices and methods of manufacture
DE2937476A1 (en) 1979-09-17 1981-04-02 Agfa-Gevaert Ag, 5090 Leverkusen DEVICE FOR MEASURING THE SURFACE TENSION
US4483825A (en) 1982-07-09 1984-11-20 Fatches Keith R Pipette and filter combination
EP0105834A3 (en) 1982-09-07 1984-10-10 Greiner Instruments AG Method and apparatus for transferring a fluid sample to microlitre and millilitre aggregates
IT1153640B (en) 1982-11-05 1987-01-14 Italiana L P Spa APPARATUS FOR THE MEASUREMENT OF THE SPEED OF ERITROSEDIMENTATION OF THE BLOOD
US5175086A (en) 1983-01-24 1992-12-29 Olympus Optical Co., Ltd. Method for effecting heterogeneous immunological analysis
US4567149A (en) 1983-03-17 1986-01-28 Mast Immunosystems, Ltd. Binding assay system and method of making and using same
US4701418A (en) 1984-03-30 1987-10-20 Dianon Systems, Inc. Method for determining lipid bound sialic acid in whole blood
US4748128A (en) 1984-03-30 1988-05-31 Dianon Systems, Inc. Method for determining lipid bound sialic acid in plasma
US4677067A (en) 1984-06-22 1987-06-30 Bio-Magnetech Corporation Magnetotactic bacteria in clinical assay, immunoassay, and cell separation procedures and the like
US5009847A (en) 1984-06-22 1991-04-23 Solomons Clive C Kit for determining blood platelet stress
GB8418828D0 (en) 1984-07-24 1984-08-30 Lab Ltd Ab Ag Calf screening
DE3586892T2 (en) 1984-09-18 1993-05-06 Sumitomo Electric Industries DEVICE FOR SEPARATING CELLS.
DE3522610A1 (en) 1985-06-12 1986-12-18 Kernforschungsanlage Jülich GmbH, 5170 Jülich CHAMBER FOR THE TREATMENT OF CELLS IN THE ELECTRIC FIELD
SE448031B (en) 1985-06-18 1987-01-12 Scomas Ab PROCEDURE AND APPARATUS FOR INDICATING THE DETECTION OF PIPETTE POSITIONS AT A TEST PLATE
CH663476A5 (en) 1985-07-08 1987-12-15 Serono Diagnostics Ltd ENCLOSURE FOR THE DETERMINATION OF ANTIBODIES OR ANTIGENS IN A BIOLOGICAL LIQUID.
US4710472A (en) * 1985-09-25 1987-12-01 The United States Of America As Represented By The Secretary Of The Navy Magnetic separation device
US5597531A (en) * 1985-10-04 1997-01-28 Immunivest Corporation Resuspendable coated magnetic particles and stable magnetic particle suspensions
US4795698A (en) 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
CH671526A5 (en) 1985-12-17 1989-09-15 Hamilton Bonaduz Ag
US4798705A (en) 1985-12-24 1989-01-17 Eastman Kodak Company Compact analyzer
US5104621A (en) 1986-03-26 1992-04-14 Beckman Instruments, Inc. Automated multi-purpose analytical chemistry processing center and laboratory work station
US4873875A (en) 1986-06-27 1989-10-17 Prism Technology, Inc. System for optically interrogating liquid samples and for withdrawing selected sample portions
US4721680A (en) 1986-08-11 1988-01-26 Multi-Technology, Inc. Methods of using micro pipette tips
FR2607407B1 (en) 1986-11-27 1991-08-02 Marteau D Autry Eric METHOD AND DEVICE FOR CALIBRATING A PIPETTE FOR SAMPLING AND DOSING
US4933291A (en) 1986-12-22 1990-06-12 Eastman Kodak Company Centrifugable pipette tip and pipette therefor
US5110727A (en) 1987-04-03 1992-05-05 Cardiovascular Diagnostics, Inc. Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles
CA1321940C (en) 1987-05-02 1993-09-07 Teruaki Itoh Apparatus for distributing sample liquid
IT210344Z2 (en) 1987-05-25 1988-12-06 Sta Te Spa EQUIPMENT FOR THE MEASUREMENT OF THE SPEED OF ERITROSEDIMENTATION OF BLOOD THROUGH PIPETTES.
US4988618A (en) 1987-11-16 1991-01-29 Gene-Trak Systems Magnetic separation device and methods for use in heterogeneous assays
FR2624757B1 (en) 1987-12-17 1990-05-25 Roussel Uclaf DEVICE FOR THE EXTRACTION OF A SEPARATE PHASE
US4895650A (en) 1988-02-25 1990-01-23 Gen-Probe Incorporated Magnetic separation rack for diagnostic assays
US4962044A (en) 1988-04-25 1990-10-09 Hoffmann-La Roche Inc. Test tube filter/dispenser apparatus and method
DE68916843T2 (en) 1988-04-26 1995-02-02 Nippon Telegraph & Telephone Microparticles, method and apparatus for collecting samples for use in labeling immune responses and method and apparatus for preparing samples.
US5354663A (en) 1988-05-04 1994-10-11 Charm Sciences, Inc. Microbial inhibition test kit and method
GB8816982D0 (en) 1988-07-16 1988-08-17 Probus Biomedical Ltd Bio-fluid assay apparatus
US5147529A (en) 1988-08-10 1992-09-15 E. I. Du Pont De Nemours And Company Method for automatically processing magnetic solid phase reagents
US5045453A (en) 1988-08-26 1991-09-03 Dianon Systems, Inc. Method for determining sialic acid in plasma
US5068089A (en) 1988-09-09 1991-11-26 Androscore Corporation Kit for testing human males for fertility
US5536475A (en) 1988-10-11 1996-07-16 Baxter International Inc. Apparatus for magnetic cell separation
WO1990007380A2 (en) 1988-12-28 1990-07-12 Stefan Miltenyi Methods and materials for high gradient magnetic separation of biological materials
US6020210A (en) * 1988-12-28 2000-02-01 Miltenvi Biotech Gmbh Methods and materials for high gradient magnetic separation of biological materials
US4931257A (en) 1989-01-05 1990-06-05 Eastman Kodak Company Positively engaged pipette and pipette support
US5437979A (en) 1989-07-24 1995-08-01 Beckman Instruments, Inc. Solid phase system for sequential reactions
FI84764C (en) 1989-09-25 1992-01-10 Labsystems Oy SPOLNINGSANORDNING.
US4970892A (en) 1989-11-15 1990-11-20 Enhorning Goran E Method and apparatus for determining surface tension or if a surfactant will keep a narrow passageway open
US5250262A (en) 1989-11-22 1993-10-05 Vettest S.A. Chemical analyzer
US5183638A (en) 1989-12-04 1993-02-02 Kabushiki Kaisha Nittec Automatic immunity analysis apparatus with magnetic particle separation
GB9020352D0 (en) 1990-09-18 1990-10-31 Anagen Ltd Assay or reaction apparatus
US5010930A (en) 1989-12-22 1991-04-30 Eastman Kodak Company Pipette and liquid transfer apparatus for dispensing liquid for analysis
AU652350B2 (en) 1990-01-10 1994-08-25 Panelfold Inc. Foldable partition
US5026526A (en) 1990-02-09 1991-06-25 Eastman Kodak Company Automated capping means for analyzer pipette
JP2626738B2 (en) 1990-03-13 1997-07-02 三共株式会社 Chemiluminescence detector
US5160329A (en) 1990-04-13 1992-11-03 T Systems Inc. Biological fluid specimen collection bag
US5084041A (en) 1990-04-13 1992-01-28 T Systems, Inc. Multicompartment biological fluid specimen collection bag
US5141871A (en) 1990-05-10 1992-08-25 Pb Diagnostic Systems, Inc. Fluid dispensing system with optical locator
US5200151A (en) 1990-05-21 1993-04-06 P B Diagnostic Systems, Inc. Fluid dispensing system having a pipette assembly with preset tip locator
US5156948A (en) 1990-07-20 1992-10-20 Christensen Dale A Method and kit for diagnosis of diseases
ATE153138T1 (en) 1990-09-26 1997-05-15 Akers Lab Inc IMPROVED DETERMINATION METHOD FOR LIGANDS
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
US5541072A (en) 1994-04-18 1996-07-30 Immunivest Corporation Method for magnetic separation featuring magnetic particles in a multi-phase system
US5622831A (en) * 1990-09-26 1997-04-22 Immunivest Corporation Methods and devices for manipulation of magnetically collected material
CA2046713A1 (en) 1990-10-16 1992-04-17 Richard M. Martinelli Amplification of midivariant dna templates
US5334538A (en) 1990-11-26 1994-08-02 V-Tech, Inc. Gold sol immunoassay system and device
US5128103A (en) 1990-12-14 1992-07-07 E. I. Du Pont De Nemours And Company Apparatus for automatically processing magnetic solid phase reagents
JPH04248447A (en) 1991-02-01 1992-09-03 Sanyo Electric Co Ltd Blood analyzer
US5137352A (en) 1991-02-05 1992-08-11 Tantec, Inc. Method and apparatus for determining the contact angle of liquid droplets on curved substrate surfaces
US5138868A (en) 1991-02-13 1992-08-18 Pb Diagnostic Systems, Inc. Calibration method for automated assay instrument
CA2384535C (en) * 1991-03-04 2006-08-15 Bayer Corporation Automated analyzer
US5242833A (en) * 1991-03-20 1993-09-07 Reference Diagnostics, Inc. Lipid fractionation
US5466574A (en) 1991-03-25 1995-11-14 Immunivest Corporation Apparatus and methods for magnetic separation featuring external magnetic means
US5186827A (en) 1991-03-25 1993-02-16 Immunicon Corporation Apparatus for magnetic separation featuring external magnetic means
US5262325A (en) 1991-04-04 1993-11-16 Ibex Technologies, Inc. Method for the enzymatic neutralization of heparin
US5171537A (en) 1991-05-06 1992-12-15 Richard E. MacDonald Activated immunodiagnostic pipette tips
US5289385A (en) 1991-06-03 1994-02-22 Abbott Laboratories Adaptive scheduling system and method for operating a biological sample analyzer with variable rinsing
FR2677453B1 (en) 1991-06-10 1993-10-08 Aegys Technology Sa METHOD AND APPARATUS FOR SPECTROPHOTOMETRIC DOSING OF AQUEOUS LIQUIDS.
US5232665A (en) 1991-07-26 1993-08-03 E. I. Du Pont De Nemours And Company Multi-linear automatic apparatus for processing immunoassays
US5670113A (en) * 1991-12-20 1997-09-23 Sibia Neurosciences, Inc. Automated analysis equipment and assay method for detecting cell surface protein and/or cytoplasmic receptor function using same
US5399497A (en) 1992-02-26 1995-03-21 Miles, Inc. Capsule chemistry sample liquid analysis system and method
US5268147A (en) 1992-02-26 1993-12-07 Miles, Inc. Reversible direction capsule chemistry sample liquid analysis system and method
US5376313A (en) 1992-03-27 1994-12-27 Abbott Laboratories Injection molding a plastic assay cuvette having low birefringence
IT1274578B (en) 1992-05-13 1997-07-17 Francesco Leopardi SAFETY CLOSURE DEVICE FOR CONTAINERS FOR ORGANIC LIQUIDS
US5270210A (en) 1992-07-16 1993-12-14 Schiapparelli Biosystems, Inc. Capacitive sensing system and wash/alignment station for a chemical analyzer
ATE195081T1 (en) 1992-09-24 2000-08-15 Amersham Pharm Biotech Uk Ltd METHOD AND DEVICE FOR MAGNETIC DEPOSITION
US5897783A (en) * 1992-09-24 1999-04-27 Amersham International Plc Magnetic separation method
US5344610A (en) 1993-02-03 1994-09-06 Eastman Kodak Company Aspirator probe with long pivot arm to minimize tip flick
FI932866A0 (en) * 1993-06-21 1993-06-21 Labsystems Oy Separeringsfoerfarande
WO1994018565A1 (en) * 1993-02-01 1994-08-18 Labsystems Oy Method and means for magnetic particle specific binding assay
AU6357394A (en) 1993-03-04 1994-09-26 Sapidyne, Inc. Assay flow apparatus and method
US5607766A (en) * 1993-03-30 1997-03-04 American Filtrona Corporation Polyethylene terephthalate sheath/thermoplastic polymer core bicomponent fibers, method of making same and products formed therefrom
US6174668B1 (en) * 1993-05-14 2001-01-16 Johnson & Johnson Clinical Diagnostics, Inc. Diagnostic compositions, elements, methods and test kits for amplification and detection of two or more target DNA's using primers having matched melting temperatures
US5403707A (en) 1993-05-14 1995-04-04 Eastman Kodak Company Diagnostic compositions, elements, methods and test kits for amplification and detection of retroviral DNA using primers having matched melting temperatures
US5578269A (en) * 1993-06-11 1996-11-26 Ortho Diagnostic Systems Inc. Automated blood analysis system with an integral centrifuge
ATE212723T1 (en) * 1993-09-17 2002-02-15 Hoffmann La Roche ANALYZER WITH A DEVICE FOR SEPARATING MAGNETIC MICROPARTICLES
EP0644426B1 (en) 1993-09-17 2004-05-06 F. Hoffmann-La Roche Ag Analyser with a device for suspending particles, and suspension method therefor
JP3115501B2 (en) * 1994-06-15 2000-12-11 プレシジョン・システム・サイエンス株式会社 Method for controlling desorption of magnetic material using dispenser and various devices processed by this method
DE4423878A1 (en) * 1994-07-07 1996-01-11 Boehringer Mannheim Gmbh Device and method for separating magnetic microparticles
FI944940A0 (en) * 1994-10-20 1994-10-20 Labsystems Oy Tvaofasigt separeringsfoerfarande
FI944939A0 (en) * 1994-10-20 1994-10-20 Labsystems Oy Foerfarande Foer separering av partiklar
US6063260A (en) * 1994-10-28 2000-05-16 Neurosearch A/S Patch clamp apparatus and technique having high throughput and low fluid volume requirements
US5599501A (en) * 1994-11-10 1997-02-04 Ciba Corning Diagnostics Corp. Incubation chamber
JP3130222B2 (en) * 1995-02-14 2001-01-31 三菱電機株式会社 Method for analyzing minute foreign matter, analyzer, and method for producing semiconductor element or liquid crystal display element using the same
US6884357B2 (en) * 1995-02-21 2005-04-26 Iqbal Waheed Siddiqi Apparatus and method for processing magnetic particles
CA2183638C (en) * 1995-03-20 2001-03-20 Tajima Hideji Liquid processing method making use of pipette device and apparatus for same
US5578270A (en) 1995-03-24 1996-11-26 Becton Dickinson And Company System for nucleic acid based diagnostic assay
EP2275821A1 (en) * 1995-07-31 2011-01-19 Precision System Science Co., Ltd Container
US6232124B1 (en) * 1996-05-06 2001-05-15 Verification Technologies, Inc. Automated fingerprint methods and chemistry for product authentication and monitoring
US5888835A (en) * 1996-05-10 1999-03-30 Chiron Diagnostics Corporation Method and apparatus for wash, resuspension, recollection and localization of magnetizable particles in assays using magnetic separation technology
CA2255658C (en) * 1996-05-20 2007-07-17 Precision System Science Co., Ltd. Method and apparatus for controlling magnetic particles by pipetting machine
US5993665A (en) * 1996-06-07 1999-11-30 Immunivest Corporation Quantitative cell analysis methods employing magnetic separation
US6790366B2 (en) * 1996-06-07 2004-09-14 Immunivest Corporation Magnetic separation apparatus and methods
US5885529A (en) * 1996-06-28 1999-03-23 Dpc Cirrus, Inc. Automated immunoassay analyzer
ATE255036T1 (en) * 1996-09-16 2003-12-15 Stomp Inc DEVICE FOR APPLYING STICKERS TO OPTICAL DISCS
US6066297A (en) * 1997-01-03 2000-05-23 Matrix Technologies Corporation Small sample volume displacement pipette tips
US5888758A (en) * 1997-03-19 1999-03-30 Integrated Biomedical Technology, Inc. Broad range total available chlorine test strip
WO1998050158A1 (en) * 1997-05-02 1998-11-12 Gen-Probe Incorporated Reaction receptacle apparatus
US5985214A (en) * 1997-05-16 1999-11-16 Aurora Biosciences Corporation Systems and methods for rapidly identifying useful chemicals in liquid samples
JP4104704B2 (en) * 1997-10-01 2008-06-18 シスメックス株式会社 Cleaning agent for automatic analyzer
US6537505B1 (en) * 1998-02-20 2003-03-25 Bio Dot, Inc. Reagent dispensing valve
EP1614475B1 (en) * 1998-05-01 2007-05-30 Gen-Probe Incorporated Device for agitating the fluid contents of a container
US20040047765A1 (en) * 1998-10-16 2004-03-11 Gordon Steven J. Automated robotic workstation and methods of operation thereof
US20030012699A1 (en) * 1998-11-18 2003-01-16 Thomas Moore Simultaneous handling of magnetic beads in a two-dimensional arrangement
WO2000042410A1 (en) * 1999-01-18 2000-07-20 Precision System Science Co., Ltd. Concentration device using magnetic particles and method therefor
DE60000386T2 (en) * 1999-01-25 2003-01-09 Hamamatsu Photonics Kk ADAPTER FOR A PIPETTE, PIPETTE FOR ABSORPTION MEASUREMENT, METHOD AND DEVICE FOR ABSORPTION MEASUREMENT
AR022333A1 (en) * 1999-01-26 2002-09-04 Anitua Aldecoa Eduardo OSEO FABRIC REGENERATOR
US6225128B1 (en) * 1999-02-19 2001-05-01 Wrs And Associates Color test card package for testing for the presence of lead
US6225126B1 (en) * 1999-02-22 2001-05-01 Haemoscope Corporation Method and apparatus for measuring hemostasis
US6193892B1 (en) * 1999-03-03 2001-02-27 Promega Corporation Magnetic separation assembly and method
US6225061B1 (en) * 1999-03-10 2001-05-01 Sequenom, Inc. Systems and methods for performing reactions in an unsealed environment
US6368872B1 (en) * 1999-10-22 2002-04-09 Tecan Trading Ag Apparatus and method for chemical processing
JP4141608B2 (en) * 2000-01-17 2008-08-27 プレシジョン・システム・サイエンス株式会社 Container transfer processing system
US6370942B1 (en) * 2000-05-15 2002-04-16 Dade Behring Inc. Method for verifying the integrity of a fluid transfer
US6672458B2 (en) * 2000-05-19 2004-01-06 Becton, Dickinson And Company System and method for manipulating magnetically responsive particles fluid samples to collect DNA or RNA from a sample
ATE419919T1 (en) * 2000-05-19 2009-01-15 Becton Dickinson Co SYSTEM AND METHOD FOR TREATING MAGNETIC PARTICLES IN TEST LIQUIDS FOR COLLECTING DNA AND RNA
TWI295688B (en) * 2000-06-07 2008-04-11 A method for inhibition of enterovirus and/or influenza virus reproduction by allophycocyanin in vitro
US20020048534A1 (en) * 2000-08-24 2002-04-25 David Storek Sample preparing arrangement and a method relating to such an arrangement
DE10057396C1 (en) * 2000-11-18 2002-04-04 Karlsruhe Forschzent Separation of e.g. biomolecules from dispersion or solution, employs magnetic particles onto which substance is sorbed, and electromagnet for their extraction
JP5193408B2 (en) * 2001-09-13 2013-05-08 ベックマン コールター, インコーポレイテッド Automatic analyzer
DE10156790A1 (en) * 2001-11-19 2003-06-18 Chemagen Biopolymer Technologi Device and method for treating magnetic particles
US8409528B2 (en) * 2003-06-19 2013-04-02 Abbott Laboratories Apparatus and method for handling fluids for analysis
US7488451B2 (en) * 2003-09-15 2009-02-10 Millipore Corporation Systems for particle manipulation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681478A (en) * 1989-12-07 1997-10-28 Diatec Instruments A/S Method and apparatus for magnetically separating and resuspending super-paramagnetic particles in a solution
US20010007312A1 (en) * 1995-02-21 2001-07-12 Siddiqi Iqbal W. Apparatus and method for mixing and separation employing magnetic particles
US6143578A (en) * 1996-05-10 2000-11-07 Bayer Corporation Method and apparatus for wash, resuspension, recollection and localization of magnetizable particles in assays using magnetic separation technology

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008075287A2 (en) * 2006-12-20 2008-06-26 Philips Intellectual Property & Standards Gmbh Method and arrangement for separating magnetic particles, magnetic particles and use magnetic particles
WO2008075287A3 (en) * 2006-12-20 2008-08-14 Philips Intellectual Property Method and arrangement for separating magnetic particles, magnetic particles and use magnetic particles
US7731899B2 (en) 2007-02-08 2010-06-08 Biokit, S.A. Apparatus and methods for dispensing sample holders
US8480954B2 (en) 2007-02-08 2013-07-09 Biokit, S.A. Apparatus and methods for dispensing sample holders
US9523699B2 (en) 2007-02-08 2016-12-20 Biokit, S.A. Apparatus and methods for dispensing sample holders
EP2208531A1 (en) 2008-12-30 2010-07-21 Atonomics A/S Distribution of particles in capillary channel by application of magnetic field

Also Published As

Publication number Publication date
CA2481545A1 (en) 2003-10-23
AU2003226075B2 (en) 2008-09-25
US7514270B2 (en) 2009-04-07
EP1494814A1 (en) 2005-01-12
AU2003226075A1 (en) 2003-10-27
US20030194799A1 (en) 2003-10-16
JP2005522679A (en) 2005-07-28

Similar Documents

Publication Publication Date Title
JP2729034B2 (en) Apparatus and method for separation of magnetic microparticles
US20220326232A1 (en) Magnetic immunosensor with trench configuration and method of use
US10145843B2 (en) Magnetic immunosensor and method of use
US7514270B2 (en) Immunoassay probe
US7300631B2 (en) Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
US10048258B2 (en) Oscillating immunoassay method and device
EP2581746B1 (en) Sample analysis device and sample analysis method
JPH02161358A (en) Automatic treatment method and apparatus
US20100300978A1 (en) Device, system and method for washing and isolating magnetic particles in a continous fluid flow
WO2011027146A2 (en) Ultrasound & magnetic method
EP2600973A1 (en) Immunoassay method and device with magnetically susceptible bead capture
MXPA04004679A (en) Method for detecting analyte(s) using magnetic colloidal particles.
JP2015121558A (en) Biosensor system for actuating magnetic particles
JP2008209330A (en) Magnetic separator and analyzing apparatus using the same
US20100279887A1 (en) Nonlinear magnetophoretic separation of biological substances
WO2020250555A1 (en) Transport device
JP2010151738A (en) Method and device for separating magnetic particle
JP2006218442A (en) Apparatus and method for b/f separation in immunoassay
WO2002090565A2 (en) Magnetic beads and uses thereof
WO2004011146A1 (en) A device and method for manipulating magnetic particles
CN207036692U (en) A kind of micro-fluidic chip fluorescence immunoassay quick detection kit
JP2005028201A (en) Magnetic separator and analytical device using the same
JP3396433B2 (en) Sample analyzer
JPH02151767A (en) Method and apparatus for adjusting sample with magnetic particle used for marking immunological reaction
WO2021029991A1 (en) Magnetic particle collection apparatus, systems, and methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2481545

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003226075

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2003583638

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003746724

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003746724

Country of ref document: EP